1. Home
  2. EQBK vs IVVD Comparison

EQBK vs IVVD Comparison

Compare EQBK & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equity Bancshares Inc.

EQBK

Equity Bancshares Inc.

HOLD

Current Price

$46.66

Market Cap

800.2M

Sector

Finance

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$2.34

Market Cap

692.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQBK
IVVD
Founded
2002
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
800.2M
692.7M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
EQBK
IVVD
Price
$46.66
$2.34
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$47.80
$8.33
AVG Volume (30 Days)
70.3K
12.4M
Earning Date
01-21-2026
11-06-2025
Dividend Yield
1.55%
N/A
EPS Growth
N/A
N/A
EPS
1.00
N/A
Revenue
$186,035,000.00
$50,039,000.00
Revenue This Year
$15.54
$103.88
Revenue Next Year
$37.88
$171.40
P/E Ratio
$46.36
N/A
Revenue Growth
17.93
332.71
52 Week Low
$34.11
$0.35
52 Week High
$47.35
$3.07

Technical Indicators

Market Signals
Indicator
EQBK
IVVD
Relative Strength Index (RSI) 76.55 54.13
Support Level $42.94 $2.15
Resistance Level $47.34 $2.59
Average True Range (ATR) 1.31 0.17
MACD 0.28 -0.02
Stochastic Oscillator 88.76 50.50

Price Performance

Historical Comparison
EQBK
IVVD

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: